Immunovant Inc.
(IMVT)
undefined
undefined%
At close: undefined
26.28
-0.17%
After-hours Dec 13, 2024, 05:19 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -259.34M | -210.96M | -156.73M | -107.43M | -66.39M | -28.60M | -136.74M |
| Depreciation & Amortization | 231.00K | 193.00K | 126.00K | 65.00K | 21.00K | 10.00K | - |
| Stock-Based Compensation | 41.12M | 32.30M | 34.24M | 18.82M | 6.96M | 1.31M | 1.81M |
| Other Working Capital | 1.41M | 5.36M | 10.52M | 3.31M | 3.84M | -474.00K | 1.44M |
| Other Non-Cash Items | 1.13M | 1.13M | 1.11M | 933.00K | 1.24M | -792.00K | 5.19M |
| Deferred Income Tax | - | - | - | -282.00K | - | - | - |
| Change in Working Capital | 2.63M | -10.85M | 15.14M | 4.57M | 4.81M | -474.00K | 1.44M |
| Operating Cash Flow | -214.23M | -188.19M | -106.11M | -83.33M | -53.36M | -28.55M | -128.30M |
| Capital Expenditures | -360.00K | -197.00K | -254.00K | -210.00K | -31.00K | -52.00K | - |
| Acquisitions | - | - | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - | - | - |
| Other Investing Acitivies | - | - | - | - | - | - | - |
| Investing Cash Flow | -360.00K | -197.00K | -254.00K | -210.00K | -31.00K | -52.00K | - |
| Debt Repayment | - | - | - | - | 37.91M | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | -318.00K | 385.00K | 200.13M | 383.11M | 109.07M | 35.58M | 128.30M |
| Financial Cash Flow | 472.43M | 70.89M | 200.13M | 383.11M | 146.97M | 35.58M | 128.30M |
| Net Cash Flow | 258.83M | -117.28M | 93.67M | 299.57M | 93.59M | 6.99M | - |
| Free Cash Flow | -214.59M | -188.39M | -106.37M | -83.54M | -53.39M | -28.60M | -128.30M |